sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global IBS-C Drug Market Insights, Forecast to 2025

Global IBS-C Drug Market Insights, Forecast to 2025

Category : Pharmaceuticals and Healthcare QY Research Pages :125
Published Date : 2019-01-16

 

IBS‑C is defined as belly pain (abdominal pain) associated with constipation. The symptoms of IBS‑C are defined as long-lasting and keep coming back. Those suffering from IBS‑C also have hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time. The important driver increasing growth in the Global Irritable Bowel Syndrome with Constipation drugs Market are modern dietary habits that are having adverse effects on the human body. Some of the dietary habits leading to constipation include high intake of foods like insoluble fiber, grains, milk, fried foods, etc. Excessive intake of caffeine and alcohol increases excretion, and this loss of water through urination can also lead to IBS. The global IBS-C Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the IBS-C Drug market based on company, product type, end user and key regions. This report studies the global market size of IBS-C Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of IBS-C Drug in these regions. This research report categorizes the global IBS-C Drug market by top players/brands, region, type and end user. This report also studies the global IBS-C Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Catalent Pharmaceuticals Solutions Nestle Abbott Laboratories Synergy Pharmaceuticals Sucampo Pharmaceuticals Novartis Pharma Astellas Pharmaceuticals Ardelyx Synthetic Biologics Teva Pharmaceutical Industries Bama-Geve Ferring BV Ironwood Pharmaceuticals Salix Pharmaceuticals Norgine Prometheus Laboratories Actavis Nordic Albireo Pharma Yuhan Corp Astrazeneca The Menarini Group Ono Pharmaceutical Market size by Product Linaclotide Lubiprostone Osmotic Laxatives Stimulant Laxatives Other Market size by End User Hospital Pharmacies Retail Pharmacies Online Pharmacies Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global IBS-C Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of IBS-C Drug market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global IBS-C Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of IBS-C Drug submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of IBS-C Drug are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of IBS-C Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 IBS-C Drug Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global IBS-C Drug Market Size Growth Rate by Product 1.4.2 Linaclotide 1.4.3 Lubiprostone 1.4.4 Osmotic Laxatives 1.4.5 Stimulant Laxatives 1.4.6 Other 1.5 Market by End User 1.5.1 Global IBS-C Drug Market Size Growth Rate by End User 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global IBS-C Drug Market Size 2.1.1 Global IBS-C Drug Revenue 2014-2025 2.1.2 Global IBS-C Drug Sales 2014-2025 2.2 IBS-C Drug Growth Rate by Regions 2.2.1 Global IBS-C Drug Sales by Regions 2.2.2 Global IBS-C Drug Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 IBS-C Drug Sales by Manufacturers 3.1.1 IBS-C Drug Sales by Manufacturers 3.1.2 IBS-C Drug Sales Market Share by Manufacturers 3.1.3 Global IBS-C Drug Market Concentration Ratio (CR5 and HHI) 3.2 IBS-C Drug Revenue by Manufacturers 3.2.1 IBS-C Drug Revenue by Manufacturers (2014-2019) 3.2.2 IBS-C Drug Revenue Share by Manufacturers (2014-2019) 3.3 IBS-C Drug Price by Manufacturers 3.4 IBS-C Drug Manufacturing Base Distribution, Product Types 3.4.1 IBS-C Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers IBS-C Drug Product Type 3.4.3 Date of International Manufacturers Enter into IBS-C Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global IBS-C Drug Sales by Product 4.2 Global IBS-C Drug Revenue by Product 4.3 IBS-C Drug Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global IBS-C Drug Breakdown Data by End User 6 North America 6.1 North America IBS-C Drug by Countries 6.1.1 North America IBS-C Drug Sales by Countries 6.1.2 North America IBS-C Drug Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America IBS-C Drug by Product 6.3 North America IBS-C Drug by End User 7 Europe 7.1 Europe IBS-C Drug by Countries 7.1.1 Europe IBS-C Drug Sales by Countries 7.1.2 Europe IBS-C Drug Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe IBS-C Drug by Product 7.3 Europe IBS-C Drug by End User 8 Asia Pacific 8.1 Asia Pacific IBS-C Drug by Countries 8.1.1 Asia Pacific IBS-C Drug Sales by Countries 8.1.2 Asia Pacific IBS-C Drug Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific IBS-C Drug by Product 8.3 Asia Pacific IBS-C Drug by End User 9 Central & South America 9.1 Central & South America IBS-C Drug by Countries 9.1.1 Central & South America IBS-C Drug Sales by Countries 9.1.2 Central & South America IBS-C Drug Revenue by Countries 9.1.3 Brazil 9.2 Central & South America IBS-C Drug by Product 9.3 Central & South America IBS-C Drug by End User 10 Middle East and Africa 10.1 Middle East and Africa IBS-C Drug by Countries 10.1.1 Middle East and Africa IBS-C Drug Sales by Countries 10.1.2 Middle East and Africa IBS-C Drug Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa IBS-C Drug by Product 10.3 Middle East and Africa IBS-C Drug by End User 11 Company Profiles 11.1 Catalent Pharmaceuticals Solutions 11.1.1 Catalent Pharmaceuticals Solutions Company Details 11.1.2 Company Business Overview 11.1.3 Catalent Pharmaceuticals Solutions IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Catalent Pharmaceuticals Solutions IBS-C Drug Products Offered 11.1.5 Catalent Pharmaceuticals Solutions Recent Development 11.2 Nestle 11.2.1 Nestle Company Details 11.2.2 Company Business Overview 11.2.3 Nestle IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Nestle IBS-C Drug Products Offered 11.2.5 Nestle Recent Development 11.3 Abbott Laboratories 11.3.1 Abbott Laboratories Company Details 11.3.2 Company Business Overview 11.3.Abbott Laboratories IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Abbott Laboratories IBS-C Drug Products Offered 11.3.5 Abbott Laboratories Recent Development 11.4 Synergy Pharmaceuticals 11.4.1 Synergy Pharmaceuticals Company Details 11.4.2 Company Business Overview 11.4.3 Synergy Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Synergy Pharmaceuticals IBS-C Drug Products Offered 11.4.5 Synergy Pharmaceuticals Recent Development 11.5 Sucampo Pharmaceuticals 11.5.1 Sucampo Pharmaceuticals Company Details 11.5.2 Company Business Overview 11.5.3 Sucampo Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Sucampo Pharmaceuticals IBS-C Drug Products Offered 11.5.5 Sucampo Pharmaceuticals Recent Development 11.6 Novartis Pharma 11.6.1 Novartis Pharma Company Details 11.6.2 Company Business Overview 11.6.3 Novartis Pharma IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Novartis Pharma IBS-C Drug Products Offered 11.6.5 Novartis Pharma Recent Development 11.7 Astellas Pharmaceuticals 11.7.1 Astellas Pharmaceuticals Company Details 11.7.2 Company Business Overview 11.7.3 Astellas Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Astellas Pharmaceuticals IBS-C Drug Products Offered 11.7.5 Astellas Pharmaceuticals Recent Development 11.8 Ardelyx 11.8.1 Ardelyx Company Details 11.8.2 Company Business Overview 11.8.3 Ardelyx IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Ardelyx IBS-C Drug Products Offered 11.8.5 Ardelyx Recent Development 11.9 Synthetic Biologics 11.9.1 Synthetic Biologics Company Details 11.9.2 Company Business Overview 11.9.3 Synthetic Biologics IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Synthetic Biologics IBS-C Drug Products Offered 11.9.5 Synthetic Biologics Recent Development 11.10 Teva Pharmaceutical Industries 11.10.1 Teva Pharmaceutical Industries Company Details 11.10.2 Company Business Overview 11.10.3 Teva Pharmaceutical Industries IBS-C Drug Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Teva Pharmaceutical Industries IBS-C Drug Products Offered 11.10.5 Teva Pharmaceutical Industries Recent Development 11.11 Bama-Geve 11.12 Ferring BV 11.13 Ironwood Pharmaceuticals 11.14 Salix Pharmaceuticals 11.15 Norgine 11.16 Prometheus Laboratories 11.17 Actavis Nordic 11.18 Albireo Pharma 11.19 Yuhan Corp 11.20 Astrazeneca 11.21 The Menarini Group 11.22 Ono Pharmaceutical 12 Future Forecast 12.1 IBS-C Drug Market Forecast by Regions 12.1.1 Global IBS-C Drug Sales Forecast by Regions 2019-2025 12.1.2 Global IBS-C Drug Revenue Forecast by Regions 2019-2025 12.2 IBS-C Drug Market Forecast by Product 12.2.1 Global IBS-C Drug Sales Forecast by Product 2019-2025 12.2.2 Global IBS-C Drug Revenue Forecast by Product 2019-2025 12.3 IBS-C Drug Market Forecast by End User 12.4 North America IBS-C Drug Forecast 12.5 Europe IBS-C Drug Forecast 12.6 Asia Pacific IBS-C Drug Forecast 12.7 Central & South America IBS-C Drug Forecast 12.8 Middle East and Africa IBS-C Drug Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 IBS-C Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables and Figures Figure IBS-C Drug Product Picture Table IBS-C Drug Market Segments Table Key Manufacturers IBS-C Drug Covered Table Global IBS-C Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global IBS-C Drug Sales Market Share by Product 2014-2025 Figure Linaclotide Product Picture Table Major Manufacturers of Linaclotide Figure Lubiprostone Product Picture Table Major Manufacturers of Lubiprostone Figure Osmotic Laxatives Product Picture Table Major Manufacturers of Osmotic Laxatives Figure Stimulant Laxatives Product Picture Table Major Manufacturers of Stimulant Laxatives Figure Other Product Picture Table Major Manufacturers of Other Table Global IBS-C Drug Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospital Pharmacies Figure Retail Pharmacies Figure Online Pharmacies Figure IBS-C Drug Report Years Considered Figure Global IBS-C Drug Market Size 2014-2025 (Million US$) Figure Global IBS-C Drug Sales 2014-2025 (K Units) Table Global IBS-C Drug Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global IBS-C Drug Sales by Regions 2014-2019 (K Units) Table Global IBS-C Drug Sales Market Share by Regions 2014-2019 Figure Global IBS-C Drug Sales Market Share by Regions 2014-2019 Figure 2018 Global IBS-C Drug Sales Market Share by Regions Table Global IBS-C Drug Revenue by Regions 2014-2019 (Million US$) Table Global IBS-C Drug Revenue Market Share by Regions 2014-2019 Figure Global IBS-C Drug Revenue Market Share by Regions 2014-2019 Figure 2018 Global IBS-C Drug Revenue Market Share by Regions Table Global IBS-C Drug Sales by Manufacturers (2014-2019) (K Units) Table Global IBS-C Drug Sales Share by Manufacturers (2014-2019) Figure Global IBS-C Drug Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table IBS-C Drug Revenue by Manufacturers (2014-2019) (Million USD) Table IBS-C Drug Revenue Share by Manufacturers (2014-2019) Figure IBS-C Drug Value Share by Manufacturers in 2018 Table Key Manufacturers IBS-C Drug Price (2014-2019) (USD/Unit) Table IBS-C Drug Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers IBS-C Drug Product Type Table Date of International Manufacturers Enter into IBS-C Drug Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global IBS-C Drug Sales by Product (2014-2019) (K Units) Table Global IBS-C Drug Sales Share by Product (2014-2019) Figure Global IBS-C Drug Sales Market Share by Product (2014-2019) Figure Global IBS-C Drug Sales Market Share by Product in 2018 Table Global IBS-C Drug Revenue by Product (2014-2019) (Million US$) Table Global IBS-C Drug Revenue Share by Product (2014-2019) Figure Global IBS-C Drug Revenue Market Share by Product (2014-2019) Figure Global IBS-C Drug Revenue Market Share by Product in 2018 Table IBS-C Drug Price by Product 2014-2019 (USD/Unit) Table Global IBS-C Drug Sales by End User (2014-2019) (K Units) Table Global IBS-C Drug Sales Share by End User (2014-2019) Figure Global Sales IBS-C Drug Market Share by End User (2014-2019) Figure Global Sales IBS-C Drug Market Share by End User in 2018 Figure North America IBS-C Drug Sales Growth Rate 2014-2019 (K Units) Figure North America IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$) Table North America IBS-C Drug Sales by Countries (2014-2019) (K Units) Table North America IBS-C Drug Sales Market Share by Countries (2014-2019) Figure 2018 North America IBS-C Drug Sales Market Share by Countries Table North America IBS-C Drug Revenue by Countries (2014-2019) (Million US$) Table North America IBS-C Drug Revenue Market Share by Countries (2014-2019) Figure 2018 North America IBS-C Drug Revenue Market Share by Countries Figure United States IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure United States IBS-C Drug Revenue Growth Rate (2014-2019) (K Units) Figure Canada IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Canada IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Mexico IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Table North America IBS-C Drug Sales by Product (2014-2019) (K Units) Table North America IBS-C Drug Sales Market Share by Product (2014-2019) Figure 2018 North America IBS-C Drug Market Share by Product Table North America IBS-C Drug Sales by End User (2014-2019) (K Units) Table North America IBS-C Drug Sales Market Share by End User (2014-2019) Figure 2018 North America IBS-C Drug Market Share by End User Figure Europe IBS-C Drug Sales Growth Rate 2014-2019 (K Units) Figure Europe IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$) Table Europe IBS-C Drug Sales by Countries (2014-2019) (K Units) Table Europe IBS-C Drug Sales Market Share by Countries (2014-2019) Figure 2018 Europe IBS-C Drug Sales Market Share by Countries Table Europe IBS-C Drug Revenue by Countries (2014-2019) (Million US$) Table Europe IBS-C Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Europe IBS-C Drug Revenue Market Share by Countries Figure Germany IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Germany IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure France IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure France IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure UK IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure UK IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Italy IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Italy IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Russia IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Russia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Table Europe IBS-C Drug Sales by Product (2014-2019) (K Units) Table Europe IBS-C Drug Sales Market Share by Product (2014-2019) Figure 2018 Europe IBS-C Drug Market Share by Product Table Europe IBS-C Drug Sales by End User (2014-2019) (K Units) Table Europe IBS-C Drug Sales Market Share by End User (2014-2019) Figure 2018 Europe IBS-C Drug Market Share by End User Figure Asia Pacific IBS-C Drug Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific IBS-C Drug Sales by Countries (2014-2019) (K Units) Table Asia Pacific IBS-C Drug Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific IBS-C Drug Sales Market Share by Countries Table Asia Pacific IBS-C Drug Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific IBS-C Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific IBS-C Drug Revenue Market Share by Countries Figure China IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure China IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Japan IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Japan IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Korea IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Korea IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure India IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure India IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Australia IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Australia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Indonesia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Malaysia IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Philippines IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Thailand IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Vietnam IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Singapore IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific IBS-C Drug Sales by Product (2014-2019) (K Units) Table Asia Pacific IBS-C Drug Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific IBS-C Drug Market Share by Product Table Asia Pacific IBS-C Drug Sales by End User (2014-2019) (K Units) Table Asia Pacific IBS-C Drug Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific IBS-C Drug Market Share by End User Figure Central & South America IBS-C Drug Sales Growth Rate 2014-2019 (K Units) Figure Central & South America IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America IBS-C Drug Sales by Countries (2014-2019) (K Units) Table Central & South America IBS-C Drug Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America IBS-C Drug Sales Market Share by Countries Table Central & South America IBS-C Drug Revenue by Countries (2014-2019) (Million US$) Table Central & South America IBS-C Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America IBS-C Drug Revenue Market Share by Countries Figure Brazil IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Brazil IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Argentina IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America IBS-C Drug Sales by Product (2014-2019) (K Units) Table Central & South America IBS-C Drug Sales Market Share by Product (2014-2019) Figure 2018 Central & South America IBS-C Drug Market Share by Product Table Central & South America IBS-C Drug Sales by End User (2014-2019) (K Units) Table Central & South America IBS-C Drug Sales Market Share by End User (2014-2019) Figure 2018 Central & South America IBS-C Drug Market Share by End User Figure Middle East and Africa IBS-C Drug Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa IBS-C Drug Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa IBS-C Drug Sales by Countries (2014-2019) (K Units) Table Middle East and Africa IBS-C Drug Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa IBS-C Drug Sales Market Share by Countries Table Middle East and Africa IBS-C Drug Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa IBS-C Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa IBS-C Drug Revenue Market Share by Countries Figure GCC Countries IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Turkey IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure Egypt IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa IBS-C Drug Sales Growth Rate (2014-2019) (K Units) Figure South Africa IBS-C Drug Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa IBS-C Drug Sales by Product (2014-2019) (K Units) Table Middle East and Africa IBS-C Drug Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa IBS-C Drug Market Share by Product Table Middle East and Africa IBS-C Drug Sales by End User (2014-2019) (K Units) Table Middle East and Africa IBS-C Drug Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa IBS-C Drug Market Share by End User Table Catalent Pharmaceuticals Solutions Company Details Table Catalent Pharmaceuticals Solutions IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Catalent Pharmaceuticals Solutions Recent Development Table Nestle Company Details Table Nestle IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Nestle Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Laboratories Recent Development Table Synergy Pharmaceuticals Company Details Table Synergy Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Synergy Pharmaceuticals Recent Development Table Sucampo Pharmaceuticals Company Details Table Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sucampo Pharmaceuticals Recent Development Table Novartis Pharma Company Details Table Novartis Pharma IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Pharma Recent Development Table Astellas Pharmaceuticals Company Details Table Astellas Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Pharmaceuticals Recent Development Table Ardelyx Company Details Table Ardelyx IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Ardelyx Recent Development Table Synthetic Biologics Company Details Table Synthetic Biologics IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Synthetic Biologics Recent Development Table Teva Pharmaceutical Industries Company Details Table Teva Pharmaceutical Industries IBS-C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceutical Industries Recent Development Table Bama-Geve Company Details Table Ferring BV Company Details Table Ironwood Pharmaceuticals Company Details Table Salix Pharmaceuticals Company Details Table Norgine Company Details Table Prometheus Laboratories Company Details Table Actavis Nordic Company Details Table Albireo Pharma Company Details Table Yuhan Corp Company Details Table Astrazeneca Company Details Table The Menarini Group Company Details Table Ono Pharmaceutical Company Details Table Global IBS-C Drug Sales Forecast by Regions 2019-2025 (K Units) Table Global IBS-C Drug Sales Market Share Forecast by Regions 2019-2025 Table Global IBS-C Drug Revenue Forecast by Regions 2019-2025 (Million US$) Table Global IBS-C Drug Revenue Market Share Forecast by Regions 2019-2025 Table Global IBS-C Drug Sales Forecast by Product 2019-2025 (K Units) Table Global IBS-C Drug Sales Market Share Forecast by Product 2019-2025 Table Global IBS-C Drug Revenue Forecast by Product 2019-2025 (Million US$) Table Global IBS-C Drug Revenue Market Share Forecast by Product 2019-2025 Table Global IBS-C Drug Sales Forecast by End User 2019-2025 (K Units) Table Global IBS-C Drug Sales Market Share Forecast by End User 2019-2025 Figure North America IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa IBS-C Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa IBS-C Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Table IBS-C Drug Value Chain Table IBS-C Drug Customers List Table IBS-C Drug Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Get Free Sample

Related Reports

Global IBS-C Drug Market Insights, Forecast to 2025

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global IBS-C Drug Market Insights, Forecast to 2025

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global IBS-C Drug Market Insights, Forecast to 2025

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global IBS-C Drug Market Insights, Forecast to 2025

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global IBS-C Drug Market Insights, Forecast to 2025

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)